A total of 29 novel quinazoline-2-aminothiazole hybrids
containing
a 4-piperidinylamide linker were designed, synthesized, and evaluated
for their anti-microbial properties against phytopathogenic fungi
and bacteria of agricultural importance. The anti-fungal assays indicated
that some of the target compounds exhibited excellent inhibitory effects
in vitro against Rhizoctonia solani. For example, 11 compounds within this series (including 4a, 4g, 4h, 4j, 4o, 4s, 4t, 4u, 4v, 4y, and 4b′) were found to possess
EC50 values (effective concentration for 50% activity)
ranging from 0.42 to 2.05 μg/mL against this pathogen. In particular,
compound 4y with a 2-chloro-6-fluorophenyl substituent
displayed a potent anti-R. solani efficacy
with EC50 = 0.42 μg/mL, nearly threefold more effective
than the commercialized fungicide Chlorothalonil (EC50 =
1.20 μg/mL) and also slightly superior to the other fungicide
Carbendazim (EC50 = 0.53 μg/mL). Moreover, compound 4y could efficiently inhibit the growth of R. solani in vivo on the potted rice plants, displaying an impressive protection
efficacy of 82.3% at 200 μg/mL, better than those of the fungicides
Carbendazim (69.8%) and Chlorothalonil (48.9%). Finally, the mechanistic
studies showed that compound 4y exerted its anti-fungal
effects by altering the mycelial morphology, increasing the cell membrane
permeability, and destroying the cell membrane integrity. On the other
hand, some compounds demonstrated good anti-bacterial effects in vitro
against Xanthomonas oryzae pv. oryzae (Xoo). Overall, the presented results
implied that 4-piperidinylamide-bridged quinazoline-2-aminothiazole
hybrids held the promise of acting as lead compounds for developing
more efficient fungicides to control R. solani.